Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001312158 | SCV000520360 | likely benign | not provided | 2020-10-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000622160 | SCV000736988 | likely benign | Cardiovascular phenotype | 2016-06-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000428842 | SCV001572488 | benign | not specified | 2021-04-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001491309 | SCV001695895 | likely benign | Myofibrillar myopathy 4 | 2024-10-12 | criteria provided, single submitter | clinical testing |